Pandemic influenza A (H1N1) 2009 vaccination in children: a UK perspective

Area of Science:

• Public Health
• Infectious Diseases
• Vaccinology

Background:

• The 2009 H1N1 influenza pandemic disproportionately affected children in the UK.
• While most cases were mild, significant mortality occurred, particularly in individuals with pre-existing conditions.

Purpose of the Study:

• To evaluate the impact of the 2009 H1N1 pandemic in the UK.
• To assess the effectiveness and uptake of pandemic influenza vaccines.
• To explore public perception and safety concerns regarding influenza vaccination.

Main Methods:

• Analysis of pandemic H1N1 influenza cases and mortality in the UK.
• Evaluation of monovalent pandemic and seasonal trivalent influenza vaccine immunogenicity and effectiveness.
• Assessment of vaccine uptake among children and healthcare workers.

Main Results:

• Pandemic H1N1 vaccines were developed rapidly but deployed late in the pandemic.
• Vaccine uptake was low in children and healthcare workers.
• Both monovalent and trivalent vaccines demonstrated immunogenicity and effectiveness, likely mitigating the third wave.
• Adjuvanted vaccines allowed antigen sparing but raised safety concerns for pediatric use.

Conclusions:

• Influenza vaccines were immunogenic and effective, reducing the third wave's impact.
• Concerns about vaccine safety and public perception of the pandemic threat may impede future responses.
• Addressing public concerns and ensuring timely vaccine availability are crucial for future pandemic preparedness.